AR021946A1 - Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas - Google Patents

Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas

Info

Publication number
AR021946A1
AR021946A1 ARP990106605A ARP990106605A AR021946A1 AR 021946 A1 AR021946 A1 AR 021946A1 AR P990106605 A ARP990106605 A AR P990106605A AR P990106605 A ARP990106605 A AR P990106605A AR 021946 A1 AR021946 A1 AR 021946A1
Authority
AR
Argentina
Prior art keywords
pheniramine
treatment
compositions containing
allergy responses
allergy
Prior art date
Application number
ARP990106605A
Other languages
English (en)
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of AR021946A1 publication Critical patent/AR021946A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composiciones que comprenden feniramina. En particular, se ha encontrado que la feniramina en combinacion con una cantidad efectiva de una povidonaproporciona confort mejorado y reduce los síntomas de sequedad en comparacion con las composiciones confeniramina sola.
ARP990106605A 1998-12-22 1999-12-21 Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas AR021946A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/219,165 US6274626B1 (en) 1998-12-22 1998-12-22 Pheniramine-containing compositions and method for treating allergic responses

Publications (1)

Publication Number Publication Date
AR021946A1 true AR021946A1 (es) 2002-09-04

Family

ID=22818149

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990106605A AR021946A1 (es) 1998-12-22 1999-12-21 Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas

Country Status (4)

Country Link
US (1) US6274626B1 (es)
AR (1) AR021946A1 (es)
AU (1) AU1834000A (es)
WO (1) WO2000037080A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7112334B2 (en) * 2001-06-05 2006-09-26 Freiberg Roberta C Allergy inhibition
US7977376B2 (en) 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
WO2004069157A2 (en) * 2003-01-17 2004-08-19 Ophthalmic Research Associates, Inc. Combinational use of long-acting and short-acting anti-histamines for ocular allergies
US20040265675A1 (en) * 2003-06-24 2004-12-30 General Electric Company Fuel Cell Flow Field Design
US20050239745A1 (en) * 2004-03-03 2005-10-27 Ophthalmic Research Associates, Inc. Novel topical ophthalmic formulations
US7288263B2 (en) * 2004-09-13 2007-10-30 Evera Laboratories, Llc Compositions and methods for treatment of skin discoloration
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
ATE463244T1 (de) * 2004-10-25 2010-04-15 Bausch & Lomb Ophthalmische zusammensetzungen und verfahren zu deren verwendung
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
US20060275516A1 (en) * 2005-06-02 2006-12-07 Ram A N S Compositions and methods for the treatment of allergic rhinitis
US20060275278A1 (en) * 2005-06-02 2006-12-07 Choy Camus K M Method and ophthalmic formulation for eye protection or treatment
WO2007127333A2 (en) 2006-04-26 2007-11-08 Aciex, Inc. Compositions for the treatment and prevention of eyelid swelling
US20090005362A1 (en) * 2007-06-26 2009-01-01 Vo Toan P Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same
EP2219630A2 (en) * 2007-11-08 2010-08-25 Aciex Therapeutics, Inc. Compositions for the treatment and prevention of eyelid swelling comprising an osmotically active ingredient and a vasoconstrictor
US8338421B2 (en) * 2008-08-01 2012-12-25 Alpha Synergy Development, Inc. Compositions and methods for reversing rebound hyperemia
US20100087550A1 (en) 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
WO2021039748A1 (ja) * 2019-08-27 2021-03-04 参天製薬株式会社 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
WO2023230525A1 (en) * 2022-05-25 2023-11-30 Viatris, Inc. Topical otic, ophthalmic, and nasal corticosteroid formulations
US20240041869A1 (en) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited Ophthalmic composition comprising an anti-allergen and a redness reduction agent
WO2024028816A1 (en) 2022-08-04 2024-02-08 Bausch + Lomb Ireland Limited Ophthalmic composition comprising pilocarpine and a redness reduction agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1303503C (en) 1987-11-10 1992-06-16 Marc Plamondon Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
JPH07116029B2 (ja) 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
CA2125060C (en) 1993-07-02 1999-03-30 Henry P. Dabrowski Ophthalmic solution for artificial tears

Also Published As

Publication number Publication date
US6274626B1 (en) 2001-08-14
WO2000037080A1 (en) 2000-06-29
AU1834000A (en) 2000-07-12

Similar Documents

Publication Publication Date Title
AR021946A1 (es) Composiciones que contienen feniramina y metodo para el tratamiento de las respuestas alergicas
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
MX9304329A (es) Molecula de arn enzimatica y celula que la incluye, para el tratamiento de enfermedades en animales y humanos.
BR9612661A (pt) Utilização de uma combinaç i de tensoatives agentes quelantes e óleos essenciais para desinfecção eficaz
ES2181845T3 (es) Uso de tomoxetina para el tratamiento de la hiperactividad inducida por trastornos de la atencion.
GT200200114A (es) Champues con alcohol de behenilo
ECSP045245A (es) N-aril-2-oxazolidinona-5-carboxamidas y sus derivados
AR019503A1 (es) Utilizacion de derivados sustituidos en 3 del estilbeno como agentes activos desodorantes en las composiciones cosmeticas
DE60106954D1 (de) Resorcin-derivate
DE69819338D1 (de) Lipid haltige zusammenstellungen und deren verwendungen
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
ATE411279T1 (de) Arylsulfonamidobenzylverbindungen
UY28049A1 (es) Derivados de (6,7-dihidro-5h-imidazo(1,2-a) imidazol-3-sulfonilamino)-propionamida
AR039146A1 (es) Composiciones limpiadoras liquidas y empleo de las mismas
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
UY26648A1 (es) Inhibidores de vasopeptidasa para tratar hipertensión sistólica aislada
NO20005548D0 (no) Mykobakterieinhibitorer
CO4840515A1 (es) Metodo de reduccion o prevencion del mal olor
AR031404A1 (es) Una composicion y metodo de aplicacion
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
PT774961E (pt) Utilizacao de selegilina para o tratamento de doencas epilepticas
ATE438701T1 (de) 3-isopropyl-1-methylcyclopentylderivate und deren verwendung bei riechstoffanwendungen
BR9612549A (pt) Método para tratamento de agressão excessiva
AR020741A1 (es) Composicion y metodo para tratar enfermedades alergicas